Progressing therapeutic development relies on the strength, reproducibility, and uniformity of the biological manufacturing system. And this is exactly what sets us apart.

Twelve years ago, we commercialized the first human pluripotent stem cell (hPSC) derived neural cell product for research and enabled its use throughout the biotechnology and pharmaceutical industries. Today we’ve translated this expertise into cell-based manufacturing to develop an unmodified, proprietary neural cell line that enables scale-up technologies for use in exosome product manufacturing. This proprietary offering, combined with our exosome separation methods, allows us to produce billions of cells and trillions of exosomes per manufacturing lot, while maintaining high-quality standards and product output consistency.

Advantages of our manufacturing system:

  • Continuous collection of product over time 
  • Closed manufacturing process
  • Automation reduces labor, manufacturing footprint
  • Our manufacturing system yields product up to five times greater than MSC derived exosomes